NCT00979186撤回不适用
A Trial to Evaluate Natural Orifice Transgastric Endoscopic Cholecystectomy With Laparoscopic Assistance
Ethicon Endo-Surgery2 个研究点 分布在 1 个国家开始时间: 2009年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 试验地点
- 2
- 主要终点
- Proportion of procedures completed
研究概览
简要总结
The study will document being able to successfully perform transgastric cholecystectomy (laparoscopic visualization) using a small collection of study surgical tools.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men and women will be enrolled in this study who:
- •Are willing to give consent and comply with evaluation and treatment schedule, able to understand and complete study questionnaires;
- •At least 18 years of age;
- •Have a clinical diagnosis of gallbladder disease indicated for cholecystectomy;
- •ASA Classification I or II (Appendix II); and
- •Have a negative serum pregnancy test (for women of childbearing potential);
- •Have the study procedure attempted.
排除标准
- •BMI > 35;
- •Use of immunosuppressive medications (within 6 months of surgery; single burst dosages and inhalable steroids are acceptable);
- •Suspicion of gallbladder cancer, tumor, polyps, or mass;
- •Acute cholecystitis or acute pancreatitis;
- •Presence of common bile duct stones;
- •History of open abdominal surgery;
- •Evidence of abdominal abscess or mass;
- •Diffuse peritonitis;
- •Use of anticoagulants or anti-platelet agents (use of daily cardio protective doses of aspirin, up to 81 mg/day, is acceptable and shall not constitute an exclusion criterion) or the presence of coagulopathy;
- •Clinical diagnosis of sepsis;
- •History of peritoneal trauma;
- •Co-morbid condition(s) that could limit the subject's ability to participate in the study or to comply with follow-up requirements, or that could impact the scientific integrity of the trial;
- •Planned concurrent surgical procedure;
- •Prior or planned major surgical procedure within 30 days before or after study procedure;
- •Previous diagnosis of intra-abdominal adhesions;
- •Participation in any other investigational device or drug trial that has not completed the primary endpoint or that clinically interferes with the current study endpoints;
- •Previously enrolled in the current series of 4 trials investigating the EES NOTES GEN1 Toolbox; or
- •Any condition which precludes compliance with the study (Investigator discretion).
结局指标
主要结局
Proportion of procedures completed
时间窗: 1 Day
Day of surgery only - study complete at end of prodecure.
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Natural Orifice Transgastric Endoscopic Surgical Removal of the GallbladderCholecystitisNCT01174069The Oregon Clinic25
已完成
不适用
Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic AssistanceAbdominal AdhesionsNCT00962650Ethicon Endo-Surgery7
已完成
不适用
A Trial to Evaluate Natural Orifice Transvaginal Endoscopic Cholecystectomy With Laparoscopic AssistanceGallbladder DiseaseNCT00889928Ethicon Endo-Surgery7
已完成
3 期
Laparoscopic Cholecystectomy vs Hybrid Natural Orifice Translumenal SurgeryCholelithiasisNCT00835250Hospital Son Llatzer60
Unknown
3 期
Laparoscopic-guided TAP Block in Patients Undergoing Gastric BypassPain, PostoperativeNCT03203070Hospital General Universitario Elche200